Fri 11/17/2017 23:31 ET
DJIA23358.24100.120.43%SOLAR24.550.140.57%GOLD1294.3916.181.25%Shanghai3136.7734.501.10%
S&P 5002578.856.710.26%BANKS26.160.020.08%OIL56.611.472.60%Nikkei22420.08417.011.86%
NASDAQ6782.7910.170.15%SEMI103.251.621.57%US/EU1.180.000.11%Futures2576.258.750.34%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Hot Shots (VERSARTIS, INC - VSAR)    Market Movement, Emerging Markets, Commodities, Options

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add VSAR
  
From: Letstrade (Rep: 193)Date: 11/14/2017 18:25
Forum: Wall Street Hot Shots - Msg #24478 - List VSAR msgs Thread #673966264 (Rec: 0)
VSAR The Drug clearly works Sounds like they should have ran the trial in various dosages to get a better feel for what dosage works best also the company should have tried different intervals like once a week and every 2 weeks trials to once again get more data and compare actually with the results that they turned in there results would probably be BETTER Then the current drug on the market that is taken daily i think that if the company gave a higher dosage there drug would work better then the current drug on the market.

Sounds like to me they shouldn't give up on this drug tho they simply need to adjust a few variables the dosing and timing that is even try every week as opposed to daily with a higher dosage and i bet money that this companies drug would have better results then the current drug on the market and not only that would only have to be taken once a week compared to everyday for the current drug...

The company also has Phase 2 Results due anytime

Some links

https://www.benzinga.com/analyst-ratings/analyst-color/17/09/10089620/versartis-somavaratan-still-has-a-path-forward-cantor-r

https://www.fiercebiotech.com/biotech/phase-3-flop-puts-versartis-life-support

https://www.biospace.com/article/releases/versartis-twice-monthly-somavaratan-for-pediatric-growth-hormone-deficiency-to-be-featured-in-oral-and-poster-presentations-at-b-impe-2017-b-/

So clearly the drug does work like i said the company failed in my view by doing a limited study of only a single dosage and once every 2 weeks

They should have done different dosage levels and also at different intervals like a higher dosage every week

Basically they should have tried a few different options I belive that by increasing the dosage and giving it every week as opposed to every 2 weeks the results would be BETTER Then what is currently avaible on the market that has to be taken daily.

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser Letstrade: Reward | Watch | IgnoreVSAR: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add VSAR
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.